340 related articles for article (PubMed ID: 21772815)
21. Striatal and nigral D1 mechanisms involved in the antiparkinsonian effects of SKF 82958 (APB): studies of tremulous jaw movements in rats.
Mayorga AJ; Trevitt JT; Conlan A; Gianutsos G; Salamone JD
Psychopharmacology (Berl); 1999 Mar; 143(1):72-81. PubMed ID: 10227082
[TBL] [Abstract][Full Text] [Related]
22. Dose-dependent effects of adenosine antagonists on tacrine-induced tremulous jaw movements.
Johnson JA; Montgomery AP; Starr ER; Ludwig J; Trevitt J
Eur J Pharmacol; 2018 Aug; 833():364-369. PubMed ID: 29883670
[TBL] [Abstract][Full Text] [Related]
23. Extracellular GABA in globus pallidus increases during the induction of oral tremor by haloperidol but not by muscarinic receptor stimulation.
Collins-Praino LE; Podurgiel SJ; Kovner R; Randall PA; Salamone JD
Behav Brain Res; 2012 Sep; 234(1):129-35. PubMed ID: 22728308
[TBL] [Abstract][Full Text] [Related]
24. The muscarinic receptor antagonist tropicamide suppresses tremulous jaw movements in a rodent model of parkinsonian tremor: possible role of M4 receptors.
Betz AJ; McLaughlin PJ; Burgos M; Weber SM; Salamone JD
Psychopharmacology (Berl); 2007 Oct; 194(3):347-59. PubMed ID: 17594079
[TBL] [Abstract][Full Text] [Related]
25. The GABA uptake inhibitor beta-alanine reduces pilocarpine-induced tremor and increases extracellular GABA in substantia nigra pars reticulata as measured by microdialysis.
Ishiwari K; Mingote S; Correa M; Trevitt JT; Carlson BB; Salamone JD
J Neurosci Methods; 2004 Dec; 140(1-2):39-46. PubMed ID: 15589332
[TBL] [Abstract][Full Text] [Related]
26. Local injections of the 5-hydroxytryptamine antagonist mianserin into substantia nigra pars reticulata block tremulous jaw movements in rats: studies with a putative model of Parkinsonian tremor.
Carlson BB; Wisniecki A; Salamone JD
Psychopharmacology (Berl); 2003 Jan; 165(3):229-37. PubMed ID: 12420151
[TBL] [Abstract][Full Text] [Related]
27. The non-selective adenosine antagonist theophylline reverses the effects of dopamine antagonism on tremor, motor activity and effort-based decision-making.
Pardo M; Paul NE; Collins-Praino LE; Salamone JD; Correa M
Pharmacol Biochem Behav; 2020 Nov; 198():173035. PubMed ID: 32910928
[TBL] [Abstract][Full Text] [Related]
28. Motor effects of GABA(A) antagonism in globus pallidus: studies of locomotion and tremulous jaw movements in rats.
Wisniecki A; Correa M; Arizzi MN; Ishiwari K; Salamone JD
Psychopharmacology (Berl); 2003 Nov; 170(2):140-9. PubMed ID: 12827348
[TBL] [Abstract][Full Text] [Related]
29. Tremulous jaw movements produced by acute tacrine administration: possible relation to parkinsonian side effects.
Mayorga AJ; Carriero DL; Cousins MS; Gianutsos G; Salamone JD
Pharmacol Biochem Behav; 1997 Feb; 56(2):273-9. PubMed ID: 9050085
[TBL] [Abstract][Full Text] [Related]
30. Effects of zonisamide on c-Fos expression under conditions of tacrine-induced tremulous jaw movements in rats: a potential mechanism underlying its anti-parkinsonian tremor effect.
Miwa H; Kubo T; Suzuki A; Kondo T
Parkinsonism Relat Disord; 2009 Jan; 15(1):30-5. PubMed ID: 18693129
[TBL] [Abstract][Full Text] [Related]
31. Blockade of adenosine A2A receptors antagonizes parkinsonian tremor in the rat tacrine model by an action on specific striatal regions.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
Exp Neurol; 2004 Sep; 189(1):182-8. PubMed ID: 15296848
[TBL] [Abstract][Full Text] [Related]
32. Effects of T-type calcium channel blockers on a parkinsonian tremor model in rats.
Miwa H; Koh J; Kajimoto Y; Kondo T
Pharmacol Biochem Behav; 2011 Feb; 97(4):656-9. PubMed ID: 21112351
[TBL] [Abstract][Full Text] [Related]
33. Involvement of adenosine A
Massari CM; Constantino LC; Marques NF; Binder LB; Valle-León M; López-Cano M; Fernández-Dueñas V; Ciruela F; Tasca CI
Purinergic Signal; 2020 Sep; 16(3):379-387. PubMed ID: 32725400
[TBL] [Abstract][Full Text] [Related]
34. Effects of H1 antagonists on cholinomimetic-induced tremulous jaw movements: studies of diphenhydramine, doxepin, and mepyramine.
Carlson BB; Trevitt JT; Salamone JD
Pharmacol Biochem Behav; 2000 Apr; 65(4):683-9. PubMed ID: 10764923
[TBL] [Abstract][Full Text] [Related]
35. Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease.
Simola N; Fenu S; Baraldi PG; Tabrizi MA; Morelli M
J Neurol Sci; 2006 Oct; 248(1-2):48-52. PubMed ID: 16780890
[TBL] [Abstract][Full Text] [Related]
36. Dopamine/adenosine interactions related to locomotion and tremor in animal models: possible relevance to parkinsonism.
Salamone JD; Ishiwari K; Betz AJ; Farrar AM; Mingote SM; Font L; Hockemeyer J; Müller CE; Correa M
Parkinsonism Relat Disord; 2008; 14 Suppl 2(Suppl 2):S130-4. PubMed ID: 18585081
[TBL] [Abstract][Full Text] [Related]
37. Pramipexole reduces parkinsonian tremor induced by pilocarpine infusion in the rat striatum.
Yasuda K; Abe H; Koganemaru G; Ikeda T; Arimori K; Ishida Y
Pharmacol Biochem Behav; 2015 Apr; 131():1-5. PubMed ID: 25622778
[TBL] [Abstract][Full Text] [Related]
38. Neuroanatomical correlates of the inhibition of tremulous jaw movements in rats by a combination of memantine and Δ
Ionov ID; Pushinskaya II; Frenkel DD; Gorev NP; Shpilevaya LA
Br J Pharmacol; 2020 Apr; 177(7):1514-1524. PubMed ID: 31696510
[TBL] [Abstract][Full Text] [Related]
39. Vacuous jaw movements induced by acute reserpine and low-dose apomorphine: possible model of parkinsonian tremor.
Salamone J; Baskin P
Pharmacol Biochem Behav; 1996 Jan; 53(1):179-83. PubMed ID: 8848448
[TBL] [Abstract][Full Text] [Related]
40. Tremulous characteristics of the vacuous jaw movements induced by pilocarpine and ventrolateral striatal dopamine depletions.
Finn M; Jassen A; Baskin P; Salamone JD
Pharmacol Biochem Behav; 1997; 57(1-2):243-9. PubMed ID: 9164578
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
